Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)
NUVOPrice: $0.17
Fair Value: 🔒
🔒score
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wir... more
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for... more
Description
Shares
| Market Cap | $5.65M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | IL | CEO | Robert Maurice Powell Jr. |
| IPO Date | 2023-06-30 | CAGR | — |
| Employees | — | Website | www.nuvocares.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 4156.28% | Total Yield | 4156.28% |
NUVO chart loading...
Fundamentals
Technicals
| Enterprise Value | $97.77M | P/E Ratio | -0.17 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 32.13 | P/B Ratio | -0.05 |
| P/CF Ratio | -0.23 | P/FCF Ratio | -0.38 |
| EPS | $-1.01 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | -0.09% |
| Operating Margin | -94.51% | Profit Margin | -191.22% |
| ROE | -0.37% | ROA | -1.04% |
| ROCE | -11.84% | Current Ratio | 0.05 |
| Quick Ratio | 0.05 | Cash Ratio | — |
| Debt/Equity | -0.17 | Interest Coverage | -378.02 |
| Altman Z Score | -7.84 | Piotroski Score | 3 |
View Holdco Nuvo Group D.G Ltd. Ordinary Shares financial charts →